Legal & General Group PLC Phathom Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 36,826 shares of PHAT stock, worth $294,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,826

Previous 36,826 -0.0%

Holding current value

$294,239

Previous $665,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.25 - $19.5 $543 - $1,033	53 Added 0.14%	36,826 $665,000
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $23,958 - $32,185	2,671 Added 7.83%	36,773 $378,000
Q1 2024 May 14, 2024	SELL	$6.21 - $11.05 $937 - $1,668	-151 Reduced 0.44%	34,102 $362,000
Q4 2023 Feb 15, 2024	BUY	$6.99 - $10.71 $1,754 - $2,688	251 Added 0.74%	34,253 $312,000
Q3 2023 Nov 14, 2023	BUY	$10.26 - $15.7 $17,708 - $27,098	1,726 Added 5.35%	34,002 $352,000
Q2 2023 Aug 14, 2023	BUY	$7.28 - $14.32 $206,446 - $406,086	28,358 Added 723.79%	32,276 $462,000
Q1 2023 May 15, 2023	SELL	$6.19 - $12.36 $21,683 - $43,297	-3,503 Reduced 47.2%	3,918 $27,000
Q3 2022 Nov 14, 2022	BUY	$6.46 - $12.11 $7,060 - $13,236	1,093 Added 17.27%	7,421 $82,000
Q2 2022 Aug 22, 2022	BUY	$6.2 - $15.5 $6,578 - $16,445	1,061 Added 20.14%	6,328 $54,000
Q1 2022 May 16, 2022	BUY	$11.55 - $20.06 $1,027 - $1,785	89 Added 1.72%	5,267 $72,000
Q3 2021 Nov 15, 2021	BUY	$30.69 - $36.83 $84,059 - $100,877	2,739 Added 112.3%	5,178 $167,000
Q2 2021 Aug 12, 2021	BUY	$32.66 - $39.87 $29,002 - $35,404	888 Added 57.25%	2,439 $82,000
Q1 2021 May 17, 2021	SELL	$33.86 - $48.68 $2,437 - $3,504	-72 Reduced 4.44%	1,551 $58,000
Q4 2020 Feb 12, 2021	BUY	$33.22 - $50.26 $9,966 - $15,078	300 Added 22.68%	1,623 $54,000
Q3 2020 Nov 13, 2020	SELL	$29.24 - $40.19 $14,298 - $19,652	-489 Reduced 26.99%	1,323 $49,000
Q2 2020 Aug 14, 2020	BUY	$25.06 - $54.6 $4,911 - $10,701	196 Added 12.13%	1,812 $60,000
Q1 2020 May 14, 2020	SELL	$24.65 - $42.83 $12,349 - $21,457	-501 Reduced 23.67%	1,616 $42,000
Q4 2019 Feb 13, 2020	BUY	$18.59 - $37.67 $39,355 - $79,747	2,117 New	2,117 $66,000

Others Institutions Holding PHAT

# of Institutions

144

Shares Held

73.6M

Call Options Held

42.3K

Put Options Held

45.7K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $313M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Phathom Pharmaceuticals, Inc. Transaction History